REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 27 filers reported holding REGULUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,701 | -6.8% | 185,183 | 0.0% | 0.03% | +25.9% |
| Q2 2023 | $272,219 | +73.5% | 185,183 | 0.0% | 0.03% | +35.0% |
| Q1 2023 | $156,943 | -38.1% | 185,183 | 0.0% | 0.02% | -33.3% |
| Q4 2022 | $253,701 | -19.5% | 185,183 | 0.0% | 0.03% | -16.7% |
| Q3 2022 | $315,000 | -17.8% | 185,183 | 0.0% | 0.04% | -7.7% |
| Q2 2022 | $383,000 | – | 185,183 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,111,049 | $1,522,137 | 0.47% |
| Sarissa Capital Management LP | 185,183 | $253,701 | 0.03% |
| FEDERATED HERMES, INC. | 3,875,578 | $5,348,298 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 40,260 | $55,156 | 0.00% |
| Virtu Financial LLC | 25,921 | $36 | 0.00% |
| GRIMES & COMPANY, INC. | 10,547 | $14,449 | 0.00% |
| ROYAL BANK OF CANADA | 80 | $0 | 0.00% |
| VANGUARD GROUP INC | 285,050 | $390,519 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 233,207 | $321,826 | 0.00% |
| UBS Group AG | 408 | $558 | 0.00% |